Archives

  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazo...

    2026-02-19

    MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide): Gold-Standard Tetrazolium Salt for In Vitro Cell Viability Assays

    Executive Summary: MTT is a well-characterized tetrazolium salt for colorimetric cell viability, metabolic activity, and cytotoxicity measurement in vitro. Its reduction to insoluble purple formazan by NADH-dependent oxidoreductases directly reflects cellular metabolic activity (https://doi.org/10.1128/aem.00371-22). MTT is membrane-permeable and cationic, distinguishing it from second-generation tetrazolium analogs (https://www.apexbt.com/mtt.html). APExBIO’s MTT (SKU B7777) is supplied at ≥98% purity and dissolves at concentrations up to 41.4 mg/mL in DMSO. Solutions are intended for short-term use, with powder storage recommended at -20°C to maintain stability.

    Biological Rationale

    Cell viability and proliferation are critical endpoints in biomedical, cancer, and drug discovery research. Quantitative assessment of these endpoints requires reagents that directly report on metabolic activity. MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide) is a yellow tetrazolium salt that is reduced in viable cells but not in dead or metabolically inactive cells. The reaction predominantly occurs via NADH-dependent mitochondrial oxidoreductases, offering specificity for intact, living cells (https://annexin-v-pe.com/index.php?g=Wap&m=Article&a=detail&id=146). As a result, MTT has become the reference substrate for colorimetric cell proliferation and cytotoxicity assays.

    Mechanism of Action of MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide)

    MTT is membrane-permeable and cationic, allowing direct entry into mammalian and bacterial cells. Within viable cells, MTT is reduced by mitochondrial (and extra-mitochondrial) NADH-dependent oxidoreductases to generate insoluble purple formazan crystals. This process does not require intermediate electron carriers, in contrast to some next-generation tetrazolium dyes (https://edu-imaging-kits.com/index.php?g=Wap&m=Article&a=detail&id=59). The accumulation of formazan is proportional to the number and metabolic activity of viable cells present. The resulting crystals can be solubilized, typically in DMSO or ethanol, for quantitative spectrophotometric analysis at 570 nm. The specificity, rapidity, and reproducibility of this conversion have positioned MTT as a gold-standard colorimetric cell viability assay reagent.

    Evidence & Benchmarks

    • MTT reduction is directly proportional to viable cell count, supporting quantitative analysis in proliferation and cytotoxicity assays (https://doi.org/10.1128/aem.00371-22).
    • MTT exhibits high solubility: ≥41.4 mg/mL in DMSO, ≥18.63 mg/mL in ethanol, ≥2.5 mg/mL in water with ultrasonication (https://www.apexbt.com/mtt.html).
    • MTT is stable at -20°C as a powder for >12 months; aqueous and organic solutions are intended for short-term use due to light and hydrolytic sensitivity (https://www.apexbt.com/mtt.html).
    • APExBIO’s MTT (B7777) offers ≥98% purity, confirmed by HPLC-MS, ensuring batch-to-batch reproducibility for sensitive applications (https://annexin-v-cy5.com/index.php?g=Wap&m=Article&a=detail&id=109).
    • Benchmarks in cancer and apoptosis research demonstrate that MTT-based readouts align with independent viability markers (https://annexin-v-pe.com/index.php?g=Wap&m=Article&a=detail&id=146).

    Applications, Limits & Misconceptions

    MTT is widely used for:

    • High-throughput drug screening in cancer and anti-infective research.
    • Apoptosis assays and metabolic activity measurement.
    • Validation of cytotoxic effects in compound libraries.

    However, the assay has defined boundaries:

    Common Pitfalls or Misconceptions

    • MTT does not distinguish between cell cycle states: It reports only on metabolic activity, not proliferation phase.
    • Formazan accumulation is cell-type dependent: Cells with low mitochondrial content may underreport viability.
    • Non-viable cells may reduce MTT under certain conditions: High levels of extra-mitochondrial reductases can artifactually generate formazan.
    • MTT is not suitable for in vivo applications: It is strictly validated for in vitro use.
    • Interference from colored compounds: Test agents with absorbance near 570 nm can confound results.

    This article extends the mechanistic details provided in previous reviews by offering updated benchmarks and addressing assay pitfalls. For discussion of translational research scenarios and integration with antibiotic resistance models, see Redefining In Vitro Cell Viability Assays, which this article supplements by focusing on classical NADH-dependent readouts and APExBIO's QC parameters.

    Workflow Integration & Parameters

    For optimal results, dissolve MTT powder in DMSO (≥41.4 mg/mL), ethanol (≥18.63 mg/mL), or water with ultrasonication (≥2.5 mg/mL). Prepare fresh solutions before use. Add MTT to cell cultures at a final assay concentration (typically 0.5 mg/mL), incubate for 1–4 hours at 37°C, then solubilize formazan crystals in DMSO or SDS-containing buffer. Read absorbance at 570 nm. For reproducibility, use APExBIO’s B7777 product, which is batch-validated for purity and solubility (https://www.apexbt.com/mtt.html). Avoid repeated freeze-thaw cycles and store aliquots protected from light at -20°C. For further details on workflow adaptation and troubleshooting, refer to MTT in Translational Research, which this article updates by reporting latest solubility and storage data for B7777.

    Conclusion & Outlook

    MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide) remains the benchmark for colorimetric cell viability and metabolic activity measurement in vitro. Its high purity, stability, and workflow adaptability, as exemplified by APExBIO’s B7777 kit, make it essential in cancer research, apoptosis assays, and drug screening. Ongoing refinements in assay design and interferences, as highlighted in recent literature, further enhance the utility and reliability of MTT-based protocols (https://doi.org/10.1128/aem.00371-22). For detailed product specifications and ordering, visit the official APExBIO MTT (B7777) page.